Healthcare -
Biotechnology - NASDAQ - US
$ 0.188
2.68 %
$ 12.3 M
Market Cap
-0.13
P/E
LYRA - TOTAL EQUITY
Total Equity LYRA - Lyra Therapeutics, Inc.
89.4 M
LAST VALUE
61.42%
2 YEAR CAGR
23.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR